Top

Published in:

01-07-2020 | Metastasis | Clinical Study

Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases

Authors: Nanthiya Sujijantarat, Christopher S. Hong, Kent A. Owusu, Aladine A. Elsamadicy, Joseph P. Antonios, Andrew B. Koo, Joachim M. Baehring, Veronica L. Chiang

Published in: Journal of Neuro-Oncology | Issue 3/2020

Abstract

Purpose

Both laser interstitial thermal therapy (LITT) and bevacizumab have been used successfully to treat radiation necrosis (RN) after radiation for brain metastases. Our purpose is to compare pre-treatment patient characteristics and outcomes between the two treatment options.

Methods

Single-institution retrospective chart review identified brain metastasis patients who developed RN between 2011 and 2018. Pre-treatment factors and treatment responses were compared between those treated with LITT versus bevacizumab.

Results

Twenty-five patients underwent LITT and 13 patients were treated with bevacizumab. The LITT cohort had a longer overall survival (median 24.8 vs. 15.2 months for bevacizumab, p = 0.003) and trended to have a longer time to local recurrence (median 12.1 months vs. 2.0 for bevacizumab), although the latter failed to achieve statistical significance (p = 0.091). LITT resulted in an initial increase in lesional volume compared to bevacizumab (p < 0.001). However, this trend reversed in the long term follow-up, with LITT resulting in a median volume decrease at 1 year post-treatment of − 64.7% (range − 96.0% to + > 100%), while bevacizumab patients saw a median volume increase of + > 100% (range − 63.0% to + > 100%), p = 0.010.

Conclusions

Our study suggests that patients undergoing LITT for RN have longer overall survival and better long-term lesional volume reduction than those treated with bevacizumab. However, it remains unclear whether our findings are due only to a difference in efficacy of the treatments or the implications of selection bias.

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet (London, England) 363(9422):1665–1672. https://doi.org/10.1016/s0140-6736(04)16250-8CrossRef

Glantz MJ, Burger PC, Friedman AH, Radtke RA, Massey EW, Schold SC Jr (1994) Treatment of radiation-induced nervous system injury with heparin and warfarin. Neurology 44(11):2020–2027. https://doi.org/10.1212/wnl.44.11.2020CrossRefPubMed

Miyatake S, Nonoguchi N, Furuse M, Yoritsune E, Miyata T, Kawabata S, Kuroiwa T (2015) Pathophysiology, diagnosis, and treatment of radiation necrosis in the brain. Neurol Med Chir (Tokyo) 55(1):50–59. https://doi.org/10.2176/nmc.ra.2014-0188CrossRef

Sneed PK, Mendez J, Vemer-van den Hoek JG, Seymour ZA, Ma L, Molinaro AM, Fogh SE, Nakamura JL, McDermott MW (2015) Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. J Neurosurg 123(2):373–386. https://doi.org/10.3171/2014.10.Jns141610CrossRefPubMed

Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR, Jackson EF (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79(5):1487–1495. https://doi.org/10.1016/j.ijrobp.2009.12.061CrossRefPubMedPubMedCentral

Sloan AE, Ahluwalia MS, Valerio-Pascua J, Manjila S, Torchia MG, Jones SE, Sunshine JL, Phillips M, Griswold MA, Clampitt M, Brewer C, Jochum J, McGraw MV, Diorio D, Ditz G, Barnett GH (2013) Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical article. J Neurosurg 118(6):1202–1219. https://doi.org/10.3171/2013.1.Jns1291CrossRefPubMed

Common Terminology Criteria for Adverse Events (CTCAE) v5.0. (2017) National Cancer Institute. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. 2020

Lin NU, Lee EQ, Aoyama H, Barani IJ, Barboriak DP, Baumert BG, Bendszus M, Brown PD, Camidge DR, Chang SM, Dancey J, de Vries EG, Gaspar LE, Harris GJ, Hodi FS, Kalkanis SN, Linskey ME, Macdonald DR, Margolin K, Mehta MP, Schiff D, Soffietti R, Suh JH, van den Bent MJ, Vogelbaum MA, Wen PY (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270–278. https://doi.org/10.1016/s1470-2045(15)70057-4CrossRefPubMed

Furuse M, Nonoguchi N, Kawabata S, Miyatake S, Kuroiwa T (2015) Delayed brain radiation necrosis: pathological review and new molecular targets for treatment. Med Mol Morphol 48(4):183–190. https://doi.org/10.1007/s00795-015-0123-2CrossRefPubMed

10.

Carpentier A, McNichols RJ, Stafford RJ, Itzcovitz J, Guichard JP, Reizine D, Delaloge S, Vicaut E, Payen D, Gowda A, George B (2008) Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors. J Neurosurg: https://doi.org/10.1227/01.neu.0000335007.07381CrossRef

11.

Torres-Reveron J, Tomasiewicz HC, Shetty A, Amankulor NM, Chiang VL (2013) Stereotactic laser induced thermotherapy (LITT): a novel treatment for brain lesions regrowing after radiosurgery. J Neurooncol 113(3):495–503. https://doi.org/10.1007/s11060-013-1142-2CrossRefPubMed

12.

Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL (2018) Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J Neurosurg 130(3):804–811. https://doi.org/10.3171/2017.11.Jns171273CrossRefPubMed

13.

Chaunzwa TL, Deng D, Leuthardt EC, Tatter SB, Mohammadi AM, Barnett GH, Chiang VL (2018) Laser thermal ablation for metastases failing radiosurgery: a multicentered retrospective study. Neurosurgery 82(1):56–63. https://doi.org/10.1093/neuros/nyx142CrossRefPubMed

14.

Rao MS, Hargreaves EL, Khan AJ, Haffty BG, Danish SF (2014) Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. J Neurosurg: https://doi.org/10.1227/neu.0000000000000332CrossRef

15.

Hong CS, Deng D, Vera A, Chiang VL (2019) Laser-interstitial thermal therapy compared to craniotomy for treatment of radiation necrosis or recurrent tumor in brain metastases failing radiosurgery. J Neurooncol 142(2):309–317. https://doi.org/10.1007/s11060-019-03097-zCrossRefPubMed

16.

Kim JH, Chung YG, Kim CY, Kim HK, Lee HK (2004) Upregulation of VEGF and FGF2 in normal rat brain after experimental intraoperative radiation therapy. J Korean Med Sci 19(6):879–886. https://doi.org/10.3346/jkms.2004.19.6.879CrossRefPubMedPubMedCentral

17.

Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Fukumoto M, Ono K (2011) The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105(2):423–431. https://doi.org/10.1007/s11060-011-0610-9CrossRefPubMed

18.

Francisco S, Genentech CA (2018) US Food and Drug Administration website. J Neurooncol. https://doi.org/10.1001/jamanetworkopen.2019.11111CrossRef

19.

Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K (2013) Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro-oncology 15(9):1257–1263. https://doi.org/10.1093/neuonc/not085CrossRefPubMedPubMedCentral

20.

Carpentier A, McNichols RJ, Stafford RJ, Guichard JP, Reizine D, Delaloge S, Vicaut E, Payen D, Gowda A, George B (2011) Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med 43(10):943–950. https://doi.org/10.1002/lsm.21138CrossRefPubMed

21.

Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M, Mikkelsen T (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94(1):63–68. https://doi.org/10.1007/s11060-009-9801-zCrossRefPubMed

Title: Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases
Authors: Nanthiya Sujijantarat
Christopher S. Hong
Kent A. Owusu
Aladine A. Elsamadicy
Joseph P. Antonios
Andrew B. Koo
Joachim M. Baehring
Veronica L. Chiang
Publication date: 01-07-2020
Publisher: Springer US
Keywords: Metastasis
Thermal Therapy
Bevacizumab
Laser
Published in: Journal of Neuro-Oncology / Issue 3/2020
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-020-03570-0

At a glance: The STEP trials

Springer Medicine

Laser interstitial thermal therapy (LITT) vs. bevacizumab for radiation necrosis in previously irradiated brain metastases

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2020

Repeat radiation with bevacizumab and minocycline in bevacizumab-refractory high grade gliomas: a prospective phase 1 trial

Long-term survival outcomes of pineal region gliomas

Fluorescein-mediated sonodynamic therapy in a rat glioma model

Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer

A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma

Early imaging marker of progressing glioblastoma: a window of opportunity